Johnson & Johnson Stock - Saturday business model review
Published on 06/20/2026 at 15:08 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Edited by ad hoc news Long-Term & Business-Model Desk. Verified prior to publication on 06/20/2026, 13:07 UTC. Details in the imprint.
Johnson & Johnson (US4781601046) has no fresh live-verified corporate hook in the provided search results, so this Saturday article uses the business-model focus from the weekday module. The available market data still show the stock trading around $228.39 in New York, with a market cap near $549.78 billion.
All news and analysis on Johnson & Johnson stock
Use this hub to track the stock, the latest company updates, and live market data in one place.
What the market data show
TradingKey lists Johnson & Johnson at $228.39, with the quote shown after the June 18 close and delayed by 15 minutes. The same page puts market capitalization at $549.78 billion and shows a trailing P/E of 26.14.
Saturday business focus
For a long-term desk view, Johnson & Johnson still stands out for its split between pharmaceuticals and medtech. That mix gives the company multiple revenue engines, even when one segment cools.
The stock also sits inside a large-cap defensive profile. That matters on quiet weekends, when investors often compare healthcare names on durability rather than short-term momentum.
What the company sells
Johnson & Johnson’s portfolio includes prescription medicines, medical devices, and consumer health products. A representative product line is Stelara in immunology, alongside device franchises in orthopedics and surgery.
Where the stock trades today
The shares of Johnson & Johnson (US4781601046) trade on the NYSE at $228.39 as of 06/18/2026, 16:00 ET.
Johnson & Johnson at a glance
- Company: Johnson & Johnson
- ISIN: US4781601046
- Ticker: JNJ
- Venue: NYSE
- Price (as of 06/18/2026, 16:00 ET): $228.39
- Market cap: $549.78 billion (as of 06/18/2026)
- Sector / Industry: Health Care / Pharmaceuticals
- Index membership: S&P 500
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
